You are here

Pfizer

Where Will Pfizer Be in 5 Years?

Where Will Pfizer Be in 5 Years?

Motley Fool

Flag link:

Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study

Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study

BioSpace

clinical trials

Duchenne Muscular Dystrophy

Flag link:

Pfizer hooks up with Ginkgo for $331M biobucks deal on unspecified targets

Pfizer hooks up with Ginkgo for $331M biobucks deal on unspecified targets

Fierce Biotech

Ginkgo Bioworks

Flag link:

Pfizer restarts production at tornado-hit plant—but supply squeezes are expected to persist

Pfizer restarts production at tornado-hit plant—but supply squeezes are expected to persist

Fierce Pharma

drug manufacturing

Flag link:

CDC recommends RSV vaccine in late pregnancy to protect newborns

CDC recommends RSV vaccine in late pregnancy to protect newborns

NPR

Flag link:

Covid Drug Paxlovid Now Less Effective Than In Early Trials—But It’s Still Great At Preventing Death

Covid Drug Paxlovid Now Less Effective Than In Early Trials—But It’s Still Great At Preventing Death

Forbes

clinical trials

Flag link:

Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts

Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts

Fierce Pharma

clinical trials

Flag link:

Pfizer forecasts 24% COVID vaccination rate in US this year

Pfizer forecasts 24% COVID vaccination rate in US this year

Yahoo/Reuters

Flag link:

EU clears review of Xtandi in earlier-stage prostate cancer

EU clears review of Xtandi in earlier-stage prostate cancer

Pharmaphorum

prostate cancer

Flag link:

Updated Covid-19 Vaccines Are Here: Will They Help Protect Against Long Covid?

Updated Covid-19 Vaccines Are Here: Will They Help Protect Against Long Covid?

Forbes

Moderna Therapeutics

Flag link:

Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines

Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines

Fierce Pharma

Moderna Therapeutics

Flag link:

Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts

Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts

Fierce Pharma

Flag link:

Pfizer and BioNTech’s COVID-19 vaccine for children receives EU recommendation

Pfizer and BioNTech’s COVID-19 vaccine for children receives EU recommendation

Biopharma Reporter

Flag link:

Pfizer ticks off Lyme vaccine milestone, linking booster shot to pediatric antibody response

Pfizer ticks off Lyme vaccine milestone, linking booster shot to pediatric antibody response

Fierce Biotech

clinical trials

Flag link:

Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation

Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation

Fierce Pharma

Moderna Therapeutics

Flag link:

Biden administration lists 10 drugs for Medicare price negotiation

Biden administration lists 10 drugs for Medicare price negotiation

Medical Marketing and Media

Bristol Myers Squibb

Boehringer Ingelheim

Flag link:

5 of the best places to work in pharma, according to employees

5 of the best places to work in pharma, according to employees

Pharma Voice

Flag link:

Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US

Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US

Clinical Trials Arena

Flag link:

Pfizer telegraphs 4th-quarter production restart at North Carolina plant damaged by tornado

Pfizer telegraphs 4th-quarter production restart at North Carolina plant damaged by tornado

Fierce Pharma

drug manufacturing

Flag link:

FDA Decisions 2023: Sandoz, Gilead Sciences and More

FDA Decisions 2023: Sandoz, Gilead Sciences and More

BioSpace

Gilead Sciences

Revance Therapeutics

Delcath Systems

Galera Therapeutics

Flag link:

Pages